CREB3L1 and breast cancer: HCC1428 luminal A breast cancer cells showed increased drug sensitivity to both palbociclib isethionate and cladribine as compared to the corresponding CREB3L1-expressing cells, however the opposite was true for lanatoside C and homoharringtonine.